Thyroid troubles linked to liver changes?
NCT ID NCT07354048
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is checking if thyroid problems (too much or too little thyroid hormone) change results of liver function tests. Researchers will measure bilirubin levels in 100 adults aged 20-60, comparing those with thyroid disease to healthy volunteers. The goal is to better understand the connection between thyroid and liver health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Jan 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients between the ages of 20-60 years old either with Hypothyroidism or Hyperthyroidism (controlled on treatment or not) and firstly diagnosed Hypothyroidism or Hyperthyroidism.
- Ages
-
20 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All patients between the ages of 20-60 years old either with Hypothyroidism or Hyperthyroidism (controlled on treatment or not) and firstly diagnosed Hypothyroidism or Hyperthyroidism. * Euthyroid controls (clinically healthy control subjects were recruited from the general population with the same socio-economic status with the subjects.) Exclusion Criteria: * Patients aged \< 20 years old. * Patients With Liver Disease. * Pregnant and lactating women. * Patients with severe infections or sepsis. * Patients with Heart Disease. * Patients who on drugs that can affect liver function such as phenothiazine, phenylbutazone, methyldopa, among others.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hyperthyroidism are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sohag University Hospital
RECRUITINGSohag, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Underactive thyroid may worsen liver scarring in fatty liver disease
- Two autoimmune conditions, one child: study probes hidden thyroid trouble
- Thyroid trouble may worsen liver scarring in fatty liver disease
- Could millions of seniors ditch a daily thyroid pill?
- Vitamin e may shield the thyroid: a new trial tests the Antioxidant's power
- Does feeling stigmatized worsen life quality for men with low testosterone?